-
Best Stocks: PulteGroup (NYSE:PHM), Immune Pharmaceuticals (NASDAQ:IMNP), ID Systems Inc. (NASDAQ:IDSY), Raven Industries Inc. (NASDAQ:RAVN)
On Monday shares of PulteGroup, Inc. (NYSE:PHM) closed at $19.90. Company’s sales growth for last 5 years was 7.30% and EPS growth for next 5 years is recorded as 5.73%. PulteGroup, Inc. (NYSE:PHM), will present at the J.P. Morgan Homebuilding & Building Products Conference on Tuesday, May 19, 2015, at 9:20 a.m. (ET). Immune Pharmaceuticals,…
-
Active Stocks: Apple Inc. (NASDAQ:AAPL), Immune Pharmaceuticals (NASDAQ:IMNP), Pacific Mercantile Bancorp (NASDAQ:PMBC), Xcel Energy Inc. (NYSE:XEL), Bio-Rad Laboratories (NYSE:BIO)
On Thursday shares of Apple Inc. (NASDAQ:AAPL) closed at $125.26. Company’s sales growth for last 5 years was 33.60% and EPS growth for next 5 years is recorded as 13.20%. Apple Inc. (NASDAQ:AAPL) announced that it will return an additional $50 billion to shareholders through a combination of dividends and stock buybacks. Apple now plans…
-
Why Need to Watch: Renren Inc. (NYSE:RENN), Immune Pharmaceuticals (NASDAQ:IMNP), Southwestern Energy Co. (NYSE:SWN), Lowe’s Companies Inc. (NYSE:LOW), Ericsson (NASDAQ:ERIC)
On last trading day Renren Inc. (NYSE:RENN) advanced 0.37% to close at $2.68. Its volatility for the week is 2.32% while volatility for the month is 3.73%. RENN’s sales growth for past 5 years was 12.20% and its EPS growth for past 5 years was 19.20%. Renren Inc. (NYSE:RENN) monthly performance is 11.67%.On 13 April,…
-
Ever Green Stocks: Immune Pharmaceuticals (NASDAQ:IMNP), Petroleo Brasileiro Petrobras (NYSE:PBR), TeleCommunication Systems (NASDAQ:TSYS), Trans World Entertainment (NASDAQ:TWMC), First Financial Northwest (NASDAQ:FFNW)
Immune Pharmaceuticals Inc. (NASDAQ:IMNP) announced the appointment Dr. Paul Nadler as acting Executive Vice President, Research & Development and Chief Medical Officer. In this position, Dr. Nadler will be responsible for overseeing the development of IMMUNE’s immunology and oncology pipeline. On Tuesday shares of Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) closed at $1.74. The office of the…
-
What’s Hot: The Empire District Electric (NYSE:EDE), Immune Pharmaceuticals (NASDAQ:IMNP), Wells Fargo Adv Inc Opport Fund (NYSEMKT:EAD), Moody’s (NYSE:MCO), STR Holdings (NYSE:STRI)
The Empire District Electric Company (NYSE:EDE) Directors declared a quarterly dividend of $0.26 per share. The dividend is payable March 16, 2015, to holders of record as of March 2, 2015. On Friday shares of The Empire District Electric Company (NYSE:EDE) closed at $27.75. Company’s sales growth for last 5 years was 2.80% and EPS…
-
Notable Ups And Down: Keurig Green Mountain (NASDAQ:GMCR), Immune Pharmaceuticals (NASDAQ:IMNP), MeetMe (NASDAQ:MEET), Sophiris Bio (NASDAQ:SPHS), Pope Resources (NASDAQ:POPE)
Keurig Green Mountain, Inc. (NASDAQ:GMCR) reported company has earned $134.58 million, or $0.82 a share in the quarter, compared with $138.23 million, or $0.91 a share for the same period last year. Operating income for the quarter was $215.93 million, compared with $226.63 million in the previous year period. On Thursday shares of Keurig Green…
-
5 Stock in Different Moves: ImmunoGen (NASDAQ:IMGN), Immune Pharmaceuticals (NASDAQ:IMNP), Comcast Corporation (NASDAQ:CMCSA), Royal Caribbean Cruises (NYSE:RCL), Wal-Mart Stores (NYSE:WMT)
ImmunoGen, Inc. (NASDAQ:IMGN) reported financial results for the three-month period ended December 31, 2014 – the second quarter of the Company’s 2015 fiscal year (2QFY2015). For the Company’s quarter ended December 31, 2014 (2QFY2015), ImmunoGen reported net income of $13.6 million, or $0.16 per basic and diluted share, compared to net income of $3.8 million,…
-
Top Stocks: IAMGOLD Corp. (NYSE:IAG), Immune Pharmaceuticals (NASDAQ:IMNP), Health Net (NYSE:HNT), Noble Energy (NYSE:NBL), Flowserve Corp. (NYSE:FLS)
IAMGOLD Corporation (NYSE:IAQ) on 22 January announces preliminary operating results for 2014 and guidance for 2015. Capital expenditures were approximately $325 million in 2014, 51% lower than 2013 and well below the 2014 guidance. Revenue for 2014 was $1.2 billion compared to $1.1 billion in 2013. On Monday shares of IAMGOLD Corp. (NYSE:IAG) closed at…
-
Drug Manufacturer Top Gainers: Impax Laboratories Inc. (NASDAQ:IPXL), GW Pharmaceuticals plc (NASDAQ:GWPH), Retrophin (NASDAQ:RTRX), Auspex Pharmaceuticals (NASDAQ:ASPX), Immune Pharmaceuticals (NASDAQ:IMNP)
Two years after federal regulators rejected its first in-house-developed drug, Impax Laboratories Inc. (NASDAQ:IPXL) won approval for its Parkinson’s disease treatment. On Thursday shares of Impax Laboratories Inc. (NASDAQ:IPXL) closed at $34.60. Company’s sales growth for last 5 years was 19.50% and EPS growth for next 5 years is recorded as 9.80%. GW Pharmaceuticals plc…
-
Stocks News Alert: Boston Scientific Corporation (NYSE:BSX), Immune Pharmaceuticals (NASDAQ:IMNP), Imperial Holdings (NYSE:IFT), Pacific Drilling S.A. (NYSE:PACD), Zix Corporation (NASDAQ:ZIXI)
Boston Scientific Corporation (NYSE:BSX) SVP David A. Pierce sold 5,000 shares of the stock in a transaction that occurred on Monday, December 8th. The stock was sold at an average price of $12.90, for a total transaction of $64,500.00. Following the sale, the senior vice president now directly owns 38,161 shares of the company’s stock,…